What is ALT.Leather?
ALT.Leather operates at the intersection of material science and sustainable manufacturing. Based in Australia, the company specializes in the development and production of plant-based leather alternatives that mimic the durability and aesthetic qualities of conventional leather without the associated environmental footprint. By focusing on innovative bio-based inputs, the firm provides a scalable solution for brands seeking to reduce their reliance on animal-derived products. Its market position is defined by a commitment to transparency, ethical sourcing, and the reduction of carbon emissions in the textile supply chain, making it a critical player in the shift toward sustainable luxury and industrial materials.
How much funding has ALT.Leather raised?
ALT.Leather has raised a total of $5.5M across 5 funding rounds:
Multiple Rounds
$5.5M
Angel/Seed (2024): $1.1M with participation from The Austin Group and Startmate
Angel/Seed (2024): $1.1M led by The Austin Group and Startmate
Angel/Seed (2024): $1.1M supported by The Austin Group and Startmate
Angel/Seed (2024): $1.1M featuring Startmate and The Austin Group
Angel/Seed (2024): $1.1M backed by Startmate and The Austin Group
Key Investors in ALT.Leather
Startmate
A prominent mentor-driven accelerator and investment community in Australia and New Zealand that supports ambitious founders through professional development and capital allocation.
The Austin Group
A minority-owned management consulting and investment firm providing strategic support, executive coaching, and operational expertise to diverse business sectors.
What's next for ALT.Leather?
Looking ahead, the strategic deployment of $1.1M will likely focus on expanding production capacity and refining the company's supply chain logistics. As the firm moves beyond its initial seed-stage milestones, the focus will shift toward securing long-term partnerships with major global retailers and automotive manufacturers who are actively seeking to integrate sustainable materials into their product lines. The backing from key regional investors provides not only the necessary liquidity but also the mentorship and network access required to navigate the complexities of scaling a hardware-intensive biomaterials business. Future growth will be contingent on the company's ability to maintain cost-competitiveness while scaling its proprietary manufacturing processes to meet international quality standards.
See full ALT.Leather company page
